한국어
English
日本語
中文(简体)
Pikray Tablets 50 mg (Alpelisib), Pikray Tablets 150 mg (Alpelisib), Pikray Tablets 200 mg (Alpelisib)
200mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Alpelisib is an anti-cancer drug component that inhibits the growth of specific breast cancer cells.
MFDS ingredient code M280473
Alpelisib is a targeted therapy component used as an anti-neoplastic agent. It is primarily used in the treatment of breast cancer patients with specific genetic mutations, serving the purpose of inhibiting the proliferation of cancer cells.
Alpelisib inhibits cell growth and division by blocking the PI3K pathway within cancer cells. This prevents cancer cells from proliferating, thus playing a role in reducing tumor size.
Approved uses differ by product. Check each product's information for its actual use.
Alpelisib is a targeted therapy that selectively inhibits the PI3K pathway, characterized by attacking only cancer cells while minimizing damage to normal cells, in contrast to traditional chemotherapy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.